F74 Origin-hd: genetic modifiers of htt cag intergenerational repeat instability in male hdgecs

A. Ehrhardt, Adam Ellenberger, E. Wild, G. Owen, S. Kwak, Elena Pak, S. Lifer, C. Sampaio
{"title":"F74 Origin-hd: genetic modifiers of htt cag intergenerational repeat instability in male hdgecs","authors":"A. Ehrhardt, Adam Ellenberger, E. Wild, G. Owen, S. Kwak, Elena Pak, S. Lifer, C. Sampaio","doi":"10.1136/jnnp-2018-ehdn.172","DOIUrl":null,"url":null,"abstract":"Background Earlier disease onset in subsequent generations, called anticipation, has been observed in HD families and is attributed to an increased CAG-repeat length in the HTT gene. CAG-repeat length mutations are referred to as ‘repeat instability’ and genome-wide association studies suggest that genomic variants function as genetic modifiers of disease onset, for example by affecting DNA repair mechanisms. Aims Origin-HD aims to investigate CAG repeat instability in germline and somatic cells and evaluate for correlations with putative genetic modifiers. Understanding the mechanisms affecting repeat instability may yield testable targets for future interventions. Study design Starting Q2 2019, over 1,000 male HDGECs (ages 18–55) will be recruited from Enroll-HD participants over about two years, approximately balanced between premanifest and manifest disease. Allele and genotype frequency for each pre-specified variant of interest will be assessed after about 500 participants have been recruited. If the predicted detectable effect size is d>0.35 in the final sample of 1,000 participants, a recruitment-by-genotype recruitment approach can be adopted in parallel to the ongoing recruitment. The repeat instability in DNA from sperm and blood of study participants will be analyzed, and genetic modifier variants will be determined.","PeriodicalId":16509,"journal":{"name":"Journal of Neurology, Neurosurgery & Psychiatry","volume":"75 1","pages":"A65 - A65"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology, Neurosurgery & Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2018-ehdn.172","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Earlier disease onset in subsequent generations, called anticipation, has been observed in HD families and is attributed to an increased CAG-repeat length in the HTT gene. CAG-repeat length mutations are referred to as ‘repeat instability’ and genome-wide association studies suggest that genomic variants function as genetic modifiers of disease onset, for example by affecting DNA repair mechanisms. Aims Origin-HD aims to investigate CAG repeat instability in germline and somatic cells and evaluate for correlations with putative genetic modifiers. Understanding the mechanisms affecting repeat instability may yield testable targets for future interventions. Study design Starting Q2 2019, over 1,000 male HDGECs (ages 18–55) will be recruited from Enroll-HD participants over about two years, approximately balanced between premanifest and manifest disease. Allele and genotype frequency for each pre-specified variant of interest will be assessed after about 500 participants have been recruited. If the predicted detectable effect size is d>0.35 in the final sample of 1,000 participants, a recruitment-by-genotype recruitment approach can be adopted in parallel to the ongoing recruitment. The repeat instability in DNA from sperm and blood of study participants will be analyzed, and genetic modifier variants will be determined.
[4]雄性植物htt - cag代际重复不稳定性的遗传修饰因子
背景:在HD家族中观察到,后代发病较早,称为预知,这是由于HTT基因中CAG-repeat长度增加。cag重复序列长度突变被称为“重复序列不稳定性”,全基因组关联研究表明,基因组变异是疾病发病的遗传修饰因子,例如通过影响DNA修复机制。Origin-HD旨在研究生殖细胞和体细胞CAG重复不稳定性,并评估其与假定的遗传修饰因子的相关性。了解影响重复不稳定性的机制可以为未来的干预措施提供可测试的目标。研究设计从2019年第二季度开始,在大约两年的时间里,将从入组的hd参与者中招募1000多名男性hdgec(年龄在18-55岁),在先兆和显性疾病之间大致平衡。在招募约500名参与者后,将评估每个预先指定的感兴趣变异的等位基因和基因型频率。如果在1,000名参与者的最终样本中预测的可检测效应量d>0.35,则可以采用按基因型招募的方法与正在进行的招募方法并行。将分析研究参与者精子和血液中DNA的重复不稳定性,并确定基因修饰变体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信